Abiopharma

News list

Varanakis Ann 🟡 adjusted position in 64.8K shares of LifeStance Health Group, Inc. (LFST) at $6.93 Transaction Date: Mar 05, 2026 | Filing ID: 099053

Full text

News bot March 10, 2026, 12:08 a.m.
🔍 Varanakis Ann (Executive)

Company: LifeStance Health Group, Inc. (LFST)

Report Date: 2026-03-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 86,331
- Total shares sold: 21,566
Detailed Transactions and Holdings:
- Acquired 86,331 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: false | shares_owned_after: 401,941.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 21,566 shares of Common Stock at $6.93 per share (Direct)
  Date: 2026-03-06 | Code: F | equity_swap_involved: false | shares_owned_after: 380,375.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Includes 86,331 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.